Literature DB >> 20731017

Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats.

Kawiya Sintara1, Duangporn Thong-Ngam, Suthiluk Patumraj, Naruemon Klaikeaw, Tanittha Chatsuwan.   

Abstract

AIM: To investigate whether curcumin could attenuate nuclear factor (NF)-kappaB p65 expression and macromolecular leakage in the gastric mucosa of Helicobacter pylori (H. pylori)-infected rats.
METHODS: Twenty-five male Sprague-Dawley rats were equally divided into five groups: control rats (Control), control rats supplemented with 600 mg/kg curcumin, H. pylori-infected rats (Hp), H. pylori-infected rats supplemented with 200 mg/kg curcumin (Hp + curI), and H. pylori-infected rats supplemented with 600 mg/kg curcumin (Hp + curII). In H. pylori-infected groups, rats were inoculated with H. pylori suspension twice a day at an interval of 4 h for 3 d. Two weeks later, 200 or 600 mg/kg curcumin was given once daily to curcumin-supplemented groups for 7 d. On the day of the experiment, macromolecular leakage in gastric mucosa was examined by intravital fluorescence microscopy. The stomach tissue was removed to examine NF-kappaB p65 expression in gastric epithelial cells by immunohistochemistry.
RESULTS: The expression of NF-kappaB p65 in gastric epithelial cells and the macromolecular leakage from gastric mucosal microcirculation significantly increased in the Hp group compared with the Control group. The percentages of NF-kappaB p65 immunoreactive cells in Control and Hp groups were 10.72% +/- 2.10% vs 16.02% +/- 2.98%, P = 0.004, respectively. The percentages of macromolecular leakage in Control and Hp groups were 10.69% +/- 1.43% vs 15.41% +/- 2.83%, P = 0.001, respectively. Curcumin supplementation in Hp + curI and Hp + curII groups significantly decreased NF-kappaB p65 immunoreactive cells and macromolecular leakage compared with results in the Hp group. The percentages of NF-kappaB p65 immunoreactive cells in Hp + curI and Hp + curII groups were 11.79% +/- 2.13% (P = 0.017) and 11.42% +/- 1.68% (P = 0.010), respectively. The percentages of macromolecular leakage in Hp + curI and Hp + curII groups were 12.32% +/- 2.13% (P = 0.025) and 12.14% +/- 1.86% (P = 0.018), respectively.
CONCLUSION: H. pylori-induced gastric inflammation in rats is associated with increased NF-kappaB activation and macromolecular leakage which can be reduced by curcumin supplementation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731017      PMCID: PMC2928457          DOI: 10.3748/wjg.v16.i32.4039

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation.

Authors:  A Kumar; S Dhawan; N J Hardegen; B B Aggarwal
Journal:  Biochem Pharmacol       Date:  1998-03-15       Impact factor: 5.858

3.  Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo.

Authors:  N Kalia; S Jacob; N J Brown; M W Reed; D Morton; K D Bardhan
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

4.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells.

Authors:  S A Sharma; M K Tummuru; M J Blaser; L D Kerr
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

6.  Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis.

Authors:  G Rieder; R A Hatz; A P Moran; A Walz; M Stolte; G Enders
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 7.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

8.  Dorsal skinfold chamber technique for intravital microscopy in nude mice.

Authors:  H A Lehr; M Leunig; M D Menger; D Nolte; K Messmer
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 9.  Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori.

Authors:  J I Wyatt
Journal:  Histopathology       Date:  1995-01       Impact factor: 5.087

Review 10.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  18 in total

Review 1.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

Authors:  David Brown
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 84.694

Review 2.  A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer.

Authors:  Atousa Haghi; Haniye Azimi; Roja Rahimi
Journal:  J Gastrointest Cancer       Date:  2017-12

3.  Curcumin prevents indomethacin-induced gastropathy in rats.

Authors:  Duangporn Thong-Ngam; Sakonwan Choochuai; Suthiluk Patumraj; Maneerat Chayanupatkul; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 4.  Helicobacter pylori and gastric cancer: Indian enigma.

Authors:  Vatsala Misra; Renu Pandey; Sri Prakash Misra; Manisha Dwivedi
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 5.  Effects of Curcumin and Its Analogues on Infectious Diseases.

Authors:  Reza Ranjbar; Hossein Bagheri; Faezeh Ghasemi; Paul C Guest; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 7.  Helicobacter pylori associated Asian enigma: Does diet deserve distinction?

Authors:  Syed Faisal Zaidi
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

8.  Simple animal model of Helicobacter pylori infection.

Authors:  Duangporn Werawatganon
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 9.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

10.  Curcumin attenuated paracetamol overdose induced hepatitis.

Authors:  Kanjana Somanawat; Duangporn Thong-Ngam; Naruemon Klaikeaw
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.